The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. Journal of the American Geriatrics Society, 53(4):695–699, April, 2005. doi abstract bibtex OBJECTIVES: To develop a 10-minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first-line physicians in detection of mild cognitive impairment (MCI), a clinical state that often progresses to dementia. DESIGN: Validation study. SETTING: A community clinic and an academic center. PARTICIPANTS: Ninety-four patients meeting MCI clinical criteria supported by psychometric measures, 93 patients with mild Alzheimer's disease (AD) (Mini-Mental State Examination (MMSE) score \textgreater or =17), and 90 healthy elderly controls (NC). MEASUREMENTS: The MoCA and MMSE were administered to all participants, and sensitivity and specificity of both measures were assessed for detection of MCI and mild AD. RESULTS: Using a cutoff score 26, the MMSE had a sensitivity of 18% to detect MCI, whereas the MoCA detected 90% of MCI subjects. In the mild AD group, the MMSE had a sensitivity of 78%, whereas the MoCA detected 100%. Specificity was excellent for both MMSE and MoCA (100% and 87%, respectively). CONCLUSION: MCI as an entity is evolving and somewhat controversial. The MoCA is a brief cognitive screening tool with high sensitivity and specificity for detecting MCI as currently conceptualized in patients performing in the normal range on the MMSE.
@article{nasreddine_montreal_2005,
title = {The {Montreal} {Cognitive} {Assessment}, {MoCA}: a brief screening tool for mild cognitive impairment},
volume = {53},
issn = {0002-8614},
shorttitle = {The {Montreal} {Cognitive} {Assessment}, {MoCA}},
doi = {10.1111/j.1532-5415.2005.53221.x},
abstract = {OBJECTIVES: To develop a 10-minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first-line physicians in detection of mild cognitive impairment (MCI), a clinical state that often progresses to dementia.
DESIGN: Validation study.
SETTING: A community clinic and an academic center.
PARTICIPANTS: Ninety-four patients meeting MCI clinical criteria supported by psychometric measures, 93 patients with mild Alzheimer's disease (AD) (Mini-Mental State Examination (MMSE) score {\textgreater} or =17), and 90 healthy elderly controls (NC).
MEASUREMENTS: The MoCA and MMSE were administered to all participants, and sensitivity and specificity of both measures were assessed for detection of MCI and mild AD.
RESULTS: Using a cutoff score 26, the MMSE had a sensitivity of 18\% to detect MCI, whereas the MoCA detected 90\% of MCI subjects. In the mild AD group, the MMSE had a sensitivity of 78\%, whereas the MoCA detected 100\%. Specificity was excellent for both MMSE and MoCA (100\% and 87\%, respectively).
CONCLUSION: MCI as an entity is evolving and somewhat controversial. The MoCA is a brief cognitive screening tool with high sensitivity and specificity for detecting MCI as currently conceptualized in patients performing in the normal range on the MMSE.},
language = {eng},
number = {4},
journal = {Journal of the American Geriatrics Society},
author = {Nasreddine, Ziad S. and Phillips, Natalie A. and Bédirian, Valérie and Charbonneau, Simon and Whitehead, Victor and Collin, Isabelle and Cummings, Jeffrey L. and Chertkow, Howard},
month = apr,
year = {2005},
pmid = {15817019},
keywords = {Aged, Alzheimer Disease, Case-Control Studies, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Psychometrics, Quebec, Reproducibility of Results, Sensitivity and Specificity},
pages = {695--699}
}
Downloads: 0
{"_id":"vPdQuqjShyW2aT7KF","bibbaseid":"nasreddine-phillips-bdirian-charbonneau-whitehead-collin-cummings-chertkow-themontrealcognitiveassessmentmocaabriefscreeningtoolformildcognitiveimpairment-2005","authorIDs":[],"author_short":["Nasreddine, Z. S.","Phillips, N. A.","Bédirian, V.","Charbonneau, S.","Whitehead, V.","Collin, I.","Cummings, J. L.","Chertkow, H."],"bibdata":{"bibtype":"article","type":"article","title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","issn":"0002-8614","shorttitle":"The Montreal Cognitive Assessment, MoCA","doi":"10.1111/j.1532-5415.2005.53221.x","abstract":"OBJECTIVES: To develop a 10-minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first-line physicians in detection of mild cognitive impairment (MCI), a clinical state that often progresses to dementia. DESIGN: Validation study. SETTING: A community clinic and an academic center. PARTICIPANTS: Ninety-four patients meeting MCI clinical criteria supported by psychometric measures, 93 patients with mild Alzheimer's disease (AD) (Mini-Mental State Examination (MMSE) score \\textgreater or =17), and 90 healthy elderly controls (NC). MEASUREMENTS: The MoCA and MMSE were administered to all participants, and sensitivity and specificity of both measures were assessed for detection of MCI and mild AD. RESULTS: Using a cutoff score 26, the MMSE had a sensitivity of 18% to detect MCI, whereas the MoCA detected 90% of MCI subjects. In the mild AD group, the MMSE had a sensitivity of 78%, whereas the MoCA detected 100%. Specificity was excellent for both MMSE and MoCA (100% and 87%, respectively). CONCLUSION: MCI as an entity is evolving and somewhat controversial. The MoCA is a brief cognitive screening tool with high sensitivity and specificity for detecting MCI as currently conceptualized in patients performing in the normal range on the MMSE.","language":"eng","number":"4","journal":"Journal of the American Geriatrics Society","author":[{"propositions":[],"lastnames":["Nasreddine"],"firstnames":["Ziad","S."],"suffixes":[]},{"propositions":[],"lastnames":["Phillips"],"firstnames":["Natalie","A."],"suffixes":[]},{"propositions":[],"lastnames":["Bédirian"],"firstnames":["Valérie"],"suffixes":[]},{"propositions":[],"lastnames":["Charbonneau"],"firstnames":["Simon"],"suffixes":[]},{"propositions":[],"lastnames":["Whitehead"],"firstnames":["Victor"],"suffixes":[]},{"propositions":[],"lastnames":["Collin"],"firstnames":["Isabelle"],"suffixes":[]},{"propositions":[],"lastnames":["Cummings"],"firstnames":["Jeffrey","L."],"suffixes":[]},{"propositions":[],"lastnames":["Chertkow"],"firstnames":["Howard"],"suffixes":[]}],"month":"April","year":"2005","pmid":"15817019","keywords":"Aged, Alzheimer Disease, Case-Control Studies, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Psychometrics, Quebec, Reproducibility of Results, Sensitivity and Specificity","pages":"695–699","bibtex":"@article{nasreddine_montreal_2005,\n\ttitle = {The {Montreal} {Cognitive} {Assessment}, {MoCA}: a brief screening tool for mild cognitive impairment},\n\tvolume = {53},\n\tissn = {0002-8614},\n\tshorttitle = {The {Montreal} {Cognitive} {Assessment}, {MoCA}},\n\tdoi = {10.1111/j.1532-5415.2005.53221.x},\n\tabstract = {OBJECTIVES: To develop a 10-minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first-line physicians in detection of mild cognitive impairment (MCI), a clinical state that often progresses to dementia.\nDESIGN: Validation study.\nSETTING: A community clinic and an academic center.\nPARTICIPANTS: Ninety-four patients meeting MCI clinical criteria supported by psychometric measures, 93 patients with mild Alzheimer's disease (AD) (Mini-Mental State Examination (MMSE) score {\\textgreater} or =17), and 90 healthy elderly controls (NC).\nMEASUREMENTS: The MoCA and MMSE were administered to all participants, and sensitivity and specificity of both measures were assessed for detection of MCI and mild AD.\nRESULTS: Using a cutoff score 26, the MMSE had a sensitivity of 18\\% to detect MCI, whereas the MoCA detected 90\\% of MCI subjects. In the mild AD group, the MMSE had a sensitivity of 78\\%, whereas the MoCA detected 100\\%. Specificity was excellent for both MMSE and MoCA (100\\% and 87\\%, respectively).\nCONCLUSION: MCI as an entity is evolving and somewhat controversial. The MoCA is a brief cognitive screening tool with high sensitivity and specificity for detecting MCI as currently conceptualized in patients performing in the normal range on the MMSE.},\n\tlanguage = {eng},\n\tnumber = {4},\n\tjournal = {Journal of the American Geriatrics Society},\n\tauthor = {Nasreddine, Ziad S. and Phillips, Natalie A. and Bédirian, Valérie and Charbonneau, Simon and Whitehead, Victor and Collin, Isabelle and Cummings, Jeffrey L. and Chertkow, Howard},\n\tmonth = apr,\n\tyear = {2005},\n\tpmid = {15817019},\n\tkeywords = {Aged, Alzheimer Disease, Case-Control Studies, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Psychometrics, Quebec, Reproducibility of Results, Sensitivity and Specificity},\n\tpages = {695--699}\n}\n\n","author_short":["Nasreddine, Z. S.","Phillips, N. A.","Bédirian, V.","Charbonneau, S.","Whitehead, V.","Collin, I.","Cummings, J. L.","Chertkow, H."],"key":"nasreddine_montreal_2005","id":"nasreddine_montreal_2005","bibbaseid":"nasreddine-phillips-bdirian-charbonneau-whitehead-collin-cummings-chertkow-themontrealcognitiveassessmentmocaabriefscreeningtoolformildcognitiveimpairment-2005","role":"author","urls":{},"keyword":["Aged","Alzheimer Disease","Case-Control Studies","Cognition Disorders","Female","Humans","Male","Neuropsychological Tests","Psychometrics","Quebec","Reproducibility of Results","Sensitivity and Specificity"],"downloads":0,"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/avargas.rava","creationDate":"2020-04-24T23:29:54.164Z","downloads":0,"keywords":["aged","alzheimer disease","case-control studies","cognition disorders","female","humans","male","neuropsychological tests","psychometrics","quebec","reproducibility of results","sensitivity and specificity"],"search_terms":["montreal","cognitive","assessment","moca","brief","screening","tool","mild","cognitive","impairment","nasreddine","phillips","bédirian","charbonneau","whitehead","collin","cummings","chertkow"],"title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","year":2005,"dataSources":["uDnPoBZzoSNdfsW67"]}